Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study)

BACKGROUND: The squamous cell carcinoma of the anus (SCCA) is a rare disease, but its incidence is markedly increasing. About 15% of patients are diagnosed at metastatic stage, and more than 20% with a localized disease treated by chemoradiotherapy (CRT) will recur. In advanced SCCA, cisplatin and 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Stefano, Jary, Marine, André, Thierry, Vendrely, Véronique, Buecher, Bruno, François, Eric, Bidard, François-Clément, Dumont, Sarah, Samalin, Emmanuelle, Peiffert, Didier, Pernot, Simon, Baba-Hamed, Nabil, El Hajbi, Farid, Bouché, Olivier, Desrame, Jérôme, Parzy, Aurélie, Zoubir, Mustapha, Louvet, Christophe, Bachet, Jean-Baptiste, Nguyen, Thierry, Abdelghani, Meher Ben, Smith, Denis, De La Fouchardière, Christelle, Aparicio, Thomas, Bennouna, Jaafar, Gornet, Jean-Marc, Jacquin, Marion, Bonnetain, Franck, Borg, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574110/
https://www.ncbi.nlm.nih.gov/pubmed/28841909
http://dx.doi.org/10.1186/s12885-017-3566-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574110/
https://www.ncbi.nlm.nih.gov/pubmed/28841909
http://dx.doi.org/10.1186/s12885-017-3566-0

Ejemplares similares